Amgen has launched a new technology and innovation site in Hyderabad.

Amgen, the largest biotechnology company in the United States, has launched its new Technology and Innovation Site in Hyderabad. The inauguration took place in Amgen's office premises near Hi-Tech City. This site launch marks a significant step towards expanding Amgen’s impact both in India and internationally, particularly enhancing the technology industry's influence and development. It brings a fresh perspective to the pharmaceutical industry in India, as Amgen expands its operations in the country. The site was inaugurated by Andhra Pradesh Chief Minister A. Revanth Reddy and Minister of IT and Industries D. Sridhar Babu, whose presence added greater significance to the event.

The event saw the participation of Amgen Chairman and CEO Robert A. Bradway, U.S. Consul General Jennifer Larson, Amgen India Representative Som Chattopadhyay, and Amgen India Managing Director Naveen Gullapalli. These leaders shared their experiences, detailing Amgen’s unique role in transforming India’s healthcare sector, especially in biotechnology, health services, and research. Their insights helped emphasize the importance of research and development in India and how Amgen is bringing new leadership to the country’s biotechnology landscape.

As part of its expansion, Amgen plans to invest $200 million (approximately ₹1600 crores) in India by 2025. This move is seen as a positive signal for the development of the scientific, bio-pharma, and healthcare industries in India. Amgen is also planning additional investments in the coming years. Not only will Hyderabad benefit from these developments, but Amgen intends to establish more research centers in other cities across India. These investments are expected to create job opportunities, contributing to the government’s goals. The company plans to launch several new projects in the future, providing more employment across the country.

The new Amgen Technology Innovation Site in Hyderabad will also enhance digital capabilities by focusing on AI and data science. With the aim of advancing its pharmaceutical range, Amgen is expanding its operations in the state. This new site will be crucial in driving digital transformation, with a focus on research, data analysis, and the progression of drug development. The site will offer opportunities to design innovative solutions in the healthcare industry, particularly in the fields of data science, AI, operational efficiency, and pharmaceutical manufacturing. This will create pathways to improve digital operations and drive breakthroughs in the sector.

For more updates on business-related developments, visit Vaartha Business.